Hims & Hers Health Inc. buy Guggenheim
Start price
27.02.24
/
50%
€12.65
Target price
27.02.25
€15.66
Performance (%)
208.38%
End price
28.02.25
€39.01
Summary
This prediction ended on 28.02.25 with a price of €39.01. With a performance of 208.38% the BUY prediction by Guggenheim was a big success. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Hims & Hers Health Inc. | -5.851% | -5.851% | 10.223% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Guggenheim for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Guggenheim from $15.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
In the thread Trading Hims & Hers Health Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Guggenheim for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€11.00
28.02.23
28.02.23
€14.12
28.02.24
28.02.24
12.73%
29.02.24
29.02.24
